StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
WLFD.TA$6470.00+0.90%
Fair $6470.00+0.0%

WLFD.TA

Willy-Food Investments Ltd

Consumer Defensive / Packaged FoodsTel Aviv

$6470.00

+58.00 (+0.90%)

Fairly Valued+0.0%Fair Value $6470.00Fund rank 27/100 · Data gapFallback financials|
SA 50/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $6.5M · quality 46.7/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 16/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

50/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · WLFD.TALocal privado en este navegador · Willy-Food Investments Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$853M

P/E

15.5x

↑

EV/EBITDA

677.7x

↑

ROE

12.8%

↑

Gross Margin

28.6%

↑

Debt/Equity

0.01

↓
52-Week Range$6470
$2598$6879

TradingView lightweight chart

WLFD.TA price, volumen y niveles de valoración

Último $6,470Periodo +875.1%
Fair value: $6,470

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+7.0%

FCF CAGR

—

FCF margin

3.9%

FCF / Net income

0.43x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $610.6M · net income $55.1M · FCF $23.6M

2022-FY → 2025-FY

Gross margin

28.6%-0.1% pts

Operating margin

12.0%+3.2% pts

Net margin

9.0%+4.9% pts

FCF margin

3.9%+4.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$610.6M$610.6M$575.8M$543.3M$498.3M
Net Income$55.1M$55.1M$44.1M$18.0M$20.5M
EBITDA$125.7M$125.7M$103.7M$47.0M$57.3M
EPS——3.341.361.56
Gross Margin28.6%28.6%28.0%22.2%28.7%
Operating Margin12.0%12.0%11.3%3.5%8.8%
Net Margin9.0%9.0%7.7%3.3%4.1%
Balance Sheet
Debt/Equity0.010.010.010.010.10
Current Ratio9.119.11———
Cash Flow
Free Cash Flow$23.6M$23.6M$-6.2M$6.5M$-1.2M
Returns
ROE12.8%12.8%11.7%5.4%6.5%
Valuation
P/E15.5215.52897.011411.031917.31
EV/EBITDA677.66677.66380.07535.54686.03
P/B198.14198.14105.2076.33125.81
Growth & Yield
Revenue Growth6.0%6.0%6.0%9.0%—
EPS Growth——145.6%-12.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +136.5%

Total return

+136.5%

Start / end P/E

n/dx → n/dx

EPS bridge

3.34 → n/d

Residual

+136.5%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+136.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.